Eileen works in the chemical and life sciences team where she supports a range of clients from start-ups to multinational companies in the fields of pharmaceuticals, industrial biotechnology, diagnostics, clean tech, chemical processes, catalysis, petrochemicals, additive manufacturing, and medical devices. She has a particular focus on technologies at the interface of chemistry and biology supporting clients active in small molecule drug discovery as well as the biologics space.
Since joining Keltie, Eileen has developed patent application drafting as well as prosecution expertise and assists with freedom to operate and validity opinions. She also manages several patent portfolios with worldwide coverage and advises on prosecution strategy in each territory in line with the client’s commercial activities.
Eileen has a broad academic background in chemistry, medicinal chemistry, biochemistry, molecular biology and synthetic biology. She completed her bachelor’s and master’s degree in chemistry at the Justus-Liebig-University in Germany in 2013. During this time, she conducted various research projects in Germany and the UK in the fields of metal catalysis, organocatalysis and biocatalysis.
From 2013 to 2017 Eileen was a PhD researcher at the interdisciplinary Manchester Institute of Biotechnology in the field of industrial biotechnology. For her doctorate she investigated the regioselective halogenation of electron rich drug scaffolds using enzymes in vivo and in vitro, which yielded several publications in peer reviewed journals. She also gained experience in the commercialisation of academic research whilst working for the university’s technology transfer company in Manchester as Enterprise Associate.
Eileen is partly qualified and training to become a fully qualified UK and European Patent Attorney. She is a native German speaker and used to handle IP matters in German. In her spare time, you can find her at the ballet either performing herself or watching in the audience.